CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study

The development of biomarkers to predict the progression of Parkinson’s disease (PD) from its earliest stage through its heterogeneous course is critical for research and therapeutic development. The Parkinson’s Progression Markers Initiative (PPMI) study is an ongoing international multicenter, pro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Acta Neuropathol
Autori principali: Kang, Ju-Hee, Mollenhauer, Brit, Coffey, Christopher S., Toledo, Jon B., Weintraub, Daniel, Galasko, Douglas R., Irwin, David J., Van Deerlin, Vivianna, Chen-Plotkin, Alice S., Caspell-Garcia, Chelsea, Waligórska, Teresa, Taylor, Peggy, Shah, Nirali, Pan, Sarah, Zero, Pawel, Frasier, Mark, Marek, Kenneth, Kieburtz, Karl, Jennings, Danna, Tanner, Caroline M., Simuni, Tanya, Singleton, Andrew, Toga, Arthur W., Chowdhury, Sohini, Trojanowski, John Q., Shaw, Leslie M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5031365/
https://ncbi.nlm.nih.gov/pubmed/27021906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00401-016-1552-2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi